Amdocs Gross Profit from 2010 to 2024
| DOX Stock | USD 86.74 0.17 0.20% |
Gross Profit | First Reported 1997-12-31 | Previous Quarter 439 M | Current Value 432.5 M | Quarterly Volatility 100.3 M |
Check Amdocs financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Amdocs main balance sheet or income statement drivers, such as Depreciation And Amortization of 181.9 M, Interest Expense of 21.3 M or Total Revenue of 3.1 B, as well as many exotic indicators such as Price To Sales Ratio of 3.4, Dividend Yield of 0.0378 or PTB Ratio of 1.38. Amdocs financial statements analysis is a perfect complement when working with Amdocs Valuation or Volatility modules.
Amdocs | Gross Profit |
Latest Amdocs' Gross Profit Growth Pattern
Below is the plot of the Gross Profit of Amdocs over the last few years. Gross profit is a required income statement account that reflects total revenue of Amdocs minus its cost of goods sold. It is profit before Amdocs operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Amdocs' Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Amdocs' overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported 1.62 B | 10 Years Trend |
|
Gross Profit |
| Timeline |
Amdocs Gross Profit Regression Statistics
| Arithmetic Mean | 1,321,960,587 | |
| Geometric Mean | 1,181,706,501 | |
| Coefficient Of Variation | 30.55 | |
| Mean Deviation | 242,870,754 | |
| Median | 1,359,499,000 | |
| Standard Deviation | 403,828,762 | |
| Sample Variance | 163077.7T | |
| Range | 1.9B | |
| R-Value | 0.67 | |
| Mean Square Error | 97172.7T | |
| R-Squared | 0.45 | |
| Significance | 0.01 | |
| Slope | 60,351,412 | |
| Total Sum of Squares | 2283087.4T |
Amdocs Gross Profit History
Other Fundumenentals of Amdocs
Amdocs Gross Profit component correlations
Click cells to compare fundamentals
About Amdocs Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Amdocs income statement, its balance sheet, and the statement of cash flows. Amdocs investors use historical funamental indicators, such as Amdocs's Gross Profit, to determine how well the company is positioned to perform in the future. Although Amdocs investors may use each financial statement separately, they are all related. The changes in Amdocs's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Amdocs's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Amdocs Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Amdocs. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 2 B | 1.1 B | |
| Gross Profit Margin | 0.35 | 0.41 |
Pair Trading with Amdocs
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amdocs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amdocs will appreciate offsetting losses from the drop in the long position's value.Moving against Amdocs Stock
| 0.78 | NN | Nextnav Acquisition Corp Tech Boost | PairCorr |
| 0.69 | EGIO | Edgio Inc Report 17th of July 2024 | PairCorr |
| 0.6 | GB | Global Blue Group | PairCorr |
| 0.55 | VERI | Veritone Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Amdocs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amdocs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amdocs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amdocs to buy it.
The correlation of Amdocs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amdocs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amdocs moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amdocs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Amdocs Correlation against competitors. For more information on how to buy Amdocs Stock please use our How to Invest in Amdocs guide.You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Complementary Tools for Amdocs Stock analysis
When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
Is Amdocs' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Amdocs. If investors know Amdocs will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Amdocs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.18 | Dividend Share 1.74 | Earnings Share 4.68 | Revenue Per Share 41.665 | Quarterly Revenue Growth 0.05 |
The market value of Amdocs is measured differently than its book value, which is the value of Amdocs that is recorded on the company's balance sheet. Investors also form their own opinion of Amdocs' value that differs from its market value or its book value, called intrinsic value, which is Amdocs' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Amdocs' market value can be influenced by many factors that don't directly affect Amdocs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Amdocs' value and its price as these two are different measures arrived at by different means. Investors typically determine if Amdocs is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Amdocs' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.